The global pet DNA testing market size is calculated at USD 447.94 million in 2025 and is forecasted to reach around USD 1,082.43 million by 2034, accelerating at a CAGR of 10.30% from 2025 to 2034. The North America market size surpassed USD 170.57 billion in 2024 and is expanding at a CAGR of 10.43% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pet DNA Testing Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pet DNA Testing Market, by Animal Type
8.1.1. Dogs
8.1.1.1. Market Revenue and Forecast
8.1.2. Cats
8.1.2.1. Market Revenue and Forecast
8.1.3. Other Animals
8.1.3.1. Market Revenue and Forecast
9.1. Pet DNA Testing Market, by Sample Type
9.1.1. Blood
9.1.1.1. Market Revenue and Forecast
9.1.2. Saliva
9.1.2.1. Market Revenue and Forecast
9.1.3. Fecal
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Pet DNA Testing Market, by Test Type
10.1.1. Breed Profile
10.1.1.1. Market Revenue and Forecast
10.1.2. Genetic Diseases
10.1.2.1. Market Revenue and Forecast
10.1.3. Health and Wellness
10.1.3.1. Market Revenue and Forecast
11.1. Pet DNA Testing Market, by End-use
11.1.1. Pet Owners
11.1.1.1. Market Revenue and Forecast
11.1.2. Breeders
11.1.2.1. Market Revenue and Forecast
11.1.3. Veterinarians
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type
12.1.2. Market Revenue and Forecast, by Sample Type
12.1.3. Market Revenue and Forecast, by Test Type
12.1.4. Market Revenue and Forecast, by End-use
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type
12.1.5.2. Market Revenue and Forecast, by Sample Type
12.1.5.3. Market Revenue and Forecast, by Test Type
12.1.5.4. Market Revenue and Forecast, by End-use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type
12.1.6.2. Market Revenue and Forecast, by Sample Type
12.1.6.3. Market Revenue and Forecast, by Test Type
12.1.6.4. Market Revenue and Forecast, by End-use
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type
12.2.2. Market Revenue and Forecast, by Sample Type
12.2.3. Market Revenue and Forecast, by Test Type
12.2.4. Market Revenue and Forecast, by End-use
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type
12.2.5.2. Market Revenue and Forecast, by Sample Type
12.2.5.3. Market Revenue and Forecast, by Test Type
12.2.5.4. Market Revenue and Forecast, by End-use
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type
12.2.6.2. Market Revenue and Forecast, by Sample Type
12.2.6.3. Market Revenue and Forecast, by Test Type
12.2.6.4. Market Revenue and Forecast, by End-use
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type
12.2.7.2. Market Revenue and Forecast, by Sample Type
12.2.7.3. Market Revenue and Forecast, by Test Type
12.2.7.4. Market Revenue and Forecast, by End-use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type
12.2.8.2. Market Revenue and Forecast, by Sample Type
12.2.8.3. Market Revenue and Forecast, by Test Type
12.2.8.4. Market Revenue and Forecast, by End-use
12.3. APAC
12.3.1. Market Revenue and Forecast, by Animal Type
12.3.2. Market Revenue and Forecast, by Sample Type
12.3.3. Market Revenue and Forecast, by Test Type
12.3.4. Market Revenue and Forecast, by End-use
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Animal Type
12.3.5.2. Market Revenue and Forecast, by Sample Type
12.3.5.3. Market Revenue and Forecast, by Test Type
12.3.5.4. Market Revenue and Forecast, by End-use
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Animal Type
12.3.6.2. Market Revenue and Forecast, by Sample Type
12.3.6.3. Market Revenue and Forecast, by Test Type
12.3.6.4. Market Revenue and Forecast, by End-use
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Animal Type
12.3.7.2. Market Revenue and Forecast, by Sample Type
12.3.7.3. Market Revenue and Forecast, by Test Type
12.3.7.4. Market Revenue and Forecast, by End-use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Animal Type
12.3.8.2. Market Revenue and Forecast, by Sample Type
12.3.8.3. Market Revenue and Forecast, by Test Type
12.3.8.4. Market Revenue and Forecast, by End-use
12.4. MEA
12.4.1. Market Revenue and Forecast, by Animal Type
12.4.2. Market Revenue and Forecast, by Sample Type
12.4.3. Market Revenue and Forecast, by Test Type
12.4.4. Market Revenue and Forecast, by End-use
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Animal Type
12.4.5.2. Market Revenue and Forecast, by Sample Type
12.4.5.3. Market Revenue and Forecast, by Test Type
12.4.5.4. Market Revenue and Forecast, by End-use
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Animal Type
12.4.6.2. Market Revenue and Forecast, by Sample Type
12.4.6.3. Market Revenue and Forecast, by Test Type
12.4.6.4. Market Revenue and Forecast, by End-use
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Animal Type
12.4.7.2. Market Revenue and Forecast, by Sample Type
12.4.7.3. Market Revenue and Forecast, by Test Type
12.4.7.4. Market Revenue and Forecast, by End-use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Animal Type
12.4.8.2. Market Revenue and Forecast, by Sample Type
12.4.8.3. Market Revenue and Forecast, by Test Type
12.4.8.4. Market Revenue and Forecast, by End-use
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Animal Type
12.5.2. Market Revenue and Forecast, by Sample Type
12.5.3. Market Revenue and Forecast, by Test Type
12.5.4. Market Revenue and Forecast, by End-use
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Animal Type
12.5.5.2. Market Revenue and Forecast, by Sample Type
12.5.5.3. Market Revenue and Forecast, by Test Type
12.5.5.4. Market Revenue and Forecast, by End-use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Animal Type
12.5.6.2. Market Revenue and Forecast, by Sample Type
12.5.6.3. Market Revenue and Forecast, by Test Type
12.5.6.4. Market Revenue and Forecast, by End-use
13.1. Zoetis Inc. (Basepaws Inc.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Mars Petcare (Wisdom Panel)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Orivet Genetic Pet Care Limited
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Embark Veterinary, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Dognomics (public: Clinomics)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. DNA MY DOG (Canadian Dog Group Ltd.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Neogen Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. EasyDNA (Genetic Technologies)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. CirclePaw (Prenetics Global Limited)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Macrogen, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample